Aperio Group’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$302K Sell
122,095
-905
-0.7% -$2.24K ﹤0.01% 2185
2020
Q3
$387K Buy
123,000
+19,855
+19% +$62.5K ﹤0.01% 1958
2020
Q2
$300K Buy
103,145
+5,895
+6% +$17.1K ﹤0.01% 2026
2020
Q1
$274K Buy
97,250
+27,670
+40% +$78K ﹤0.01% 1963
2019
Q4
$226K Sell
69,580
-589
-0.8% -$1.91K ﹤0.01% 2166
2019
Q3
$152K Sell
70,169
-13,620
-16% -$29.5K ﹤0.01% 2206
2019
Q2
$263K Sell
83,789
-1,247
-1% -$3.91K ﹤0.01% 2074
2019
Q1
$316K Buy
85,036
+18,780
+28% +$69.8K ﹤0.01% 1975
2018
Q4
$192K Sell
66,256
-46,265
-41% -$134K ﹤0.01% 2143
2018
Q3
$296K Sell
112,521
-110,796
-50% -$291K ﹤0.01% 2020
2018
Q2
$523K Sell
223,317
-55,181
-20% -$129K ﹤0.01% 1724
2018
Q1
$819K Buy
278,498
+10,857
+4% +$31.9K ﹤0.01% 1435
2017
Q4
$733K Buy
267,641
+50,810
+23% +$139K ﹤0.01% 1501
2017
Q3
$735K Buy
216,831
+695
+0.3% +$2.36K ﹤0.01% 1456
2017
Q2
$534K Sell
216,136
-128,935
-37% -$319K ﹤0.01% 1616
2017
Q1
$783K Buy
345,071
+48,413
+16% +$110K 0.01% 1280
2016
Q4
$629K Sell
296,658
-64,141
-18% -$136K ﹤0.01% 1374
2016
Q3
$1.21M Buy
360,799
+33,037
+10% +$111K 0.01% 1019
2016
Q2
$1.03M Sell
327,762
-163,271
-33% -$513K 0.01% 1059
2016
Q1
$1.64M Buy
491,033
+266,173
+118% +$886K 0.01% 856
2015
Q4
$796K Sell
224,860
-379,937
-63% -$1.34M 0.01% 1111
2015
Q3
$3.04M Sell
604,797
-391,451
-39% -$1.97M 0.03% 594
2015
Q2
$6.41M Buy
996,248
+305,759
+44% +$1.97M 0.07% 343
2015
Q1
$4.86M Buy
690,489
+500,064
+263% +$3.52M 0.05% 412
2014
Q4
$1.47M Sell
190,425
-214,785
-53% -$1.66M 0.02% 741
2014
Q3
$3.03M Buy
405,210
+324,126
+400% +$2.42M 0.04% 494
2014
Q2
$785K Buy
81,084
+20,510
+34% +$199K 0.01% 937
2014
Q1
$503K Buy
+60,574
New +$503K 0.01% 1326
2013
Q4
Sell
-70,418
Closed -$561K 1189
2013
Q3
$561K Buy
70,418
+26,053
+59% +$208K 0.01% 1093
2013
Q2
$342K Buy
+44,365
New +$342K 0.01% 1199